tradingkey.logo
tradingkey.logo
Search

Sino Biopharmaceutical Says Application For Clinical Trial On TQB3205 "Pan-Kras Inhibitor" Approved By FDA

ReutersApr 9, 2026 1:30 AM

- Sino Biopharmaceutical Ltd 1177.HK:

  • APPLICATION FOR CLINICAL TRIAL ON TQB3205 "PAN-KRAS INHIBITOR" APPROVED BY FDA

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI